Links between Vitamin K, Ferroptosis and SARS-CoV-2 Infection.
Jarosław NuszkiewiczPaweł SutkowyMarcin WróblewskiMarta PawłowskaRoland WesołowskiJoanna WróblewskaAlina WoźniakPublished in: Antioxidants (Basel, Switzerland) (2023)
Ferroptosis is a recently discovered form of programmed cell death. It is characterized by the accumulation of iron and lipid hydroperoxides in cells. Vitamin K is known to have antioxidant properties and plays a role in reducing oxidative stress, particularly in lipid cell membranes. Vitamin K reduces the level of reactive oxygen species by modulating the expression of antioxidant enzymes. Additionally, vitamin K decreases inflammation and potentially prevents ferroptosis. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection leading to coronavirus disease 2019 (COVID-19) is associated with oxidant-antioxidant imbalance. Studies have shown that intensified ferroptosis occurs in various tissues and cells affected by COVID-19. Vitamin K supplementation during SARS-CoV-2 infection may have a positive effect on reducing the severity of the disease. Preliminary research suggests that vitamin K may reduce lipid peroxidation and inhibit ferroptosis, potentially contributing to its therapeutic effects in COVID-19 patients. The links between ferroptosis, vitamin K, and SARS-CoV-2 infection require further investigation, particularly in the context of developing potential treatment strategies for COVID-19.
Keyphrases
- respiratory syndrome coronavirus
- coronavirus disease
- cell death
- sars cov
- oxidative stress
- cell cycle arrest
- induced apoptosis
- anti inflammatory
- reactive oxygen species
- endoplasmic reticulum stress
- signaling pathway
- ischemia reperfusion injury
- fatty acid
- dna damage
- risk assessment
- poor prognosis
- stem cells
- mouse model
- human health
- bone marrow
- climate change
- mesenchymal stem cells